Concepts (234)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Electroconvulsive Therapy | 31 | 2021 | 402 | 2.760 |
Why?
|
| Depressive Disorder, Major | 20 | 2021 | 438 | 1.960 |
Why?
|
| Telemedicine | 13 | 2017 | 699 | 1.150 |
Why?
|
| Stress Disorders, Post-Traumatic | 18 | 2016 | 1506 | 1.040 |
Why?
|
| Antidepressive Agents | 8 | 2018 | 216 | 0.980 |
Why?
|
| Venlafaxine Hydrochloride | 6 | 2021 | 42 | 0.830 |
Why?
|
| Ketamine | 2 | 2015 | 57 | 0.770 |
Why?
|
| Anesthetics, General | 1 | 2019 | 3 | 0.710 |
Why?
|
| Veterans | 13 | 2016 | 904 | 0.690 |
Why?
|
| Oral Health | 1 | 2019 | 49 | 0.670 |
Why?
|
| Depressive Disorder | 9 | 2017 | 621 | 0.600 |
Why?
|
| Diabetes Mellitus, Type 2 | 7 | 2021 | 1085 | 0.590 |
Why?
|
| Depression | 7 | 2016 | 942 | 0.510 |
Why?
|
| Excitatory Amino Acid Antagonists | 1 | 2015 | 128 | 0.490 |
Why?
|
| Psychotherapy | 4 | 2017 | 253 | 0.480 |
Why?
|
| Videoconferencing | 3 | 2009 | 43 | 0.450 |
Why?
|
| Nortriptyline | 7 | 2015 | 28 | 0.440 |
Why?
|
| Psychotic Disorders | 3 | 2009 | 157 | 0.440 |
Why?
|
| Schizophrenia | 2 | 2010 | 206 | 0.390 |
Why?
|
| Psychiatry | 3 | 2014 | 112 | 0.380 |
Why?
|
| Humans | 70 | 2021 | 68525 | 0.350 |
Why?
|
| Lithium Compounds | 4 | 2017 | 15 | 0.350 |
Why?
|
| Quality of Life | 5 | 2019 | 1515 | 0.350 |
Why?
|
| Treatment Outcome | 26 | 2021 | 7028 | 0.350 |
Why?
|
| Male | 54 | 2019 | 37281 | 0.350 |
Why?
|
| Guideline Adherence | 2 | 2010 | 284 | 0.340 |
Why?
|
| Psychotherapy, Group | 2 | 2010 | 55 | 0.330 |
Why?
|
| Psychiatric Status Rating Scales | 15 | 2018 | 782 | 0.320 |
Why?
|
| Female | 53 | 2019 | 38015 | 0.310 |
Why?
|
| Middle Aged | 42 | 2021 | 21119 | 0.300 |
Why?
|
| Professional Competence | 1 | 2007 | 100 | 0.300 |
Why?
|
| Mental Disorders | 6 | 2015 | 659 | 0.260 |
Why?
|
| Aged | 28 | 2021 | 14842 | 0.260 |
Why?
|
| Case Management | 2 | 2017 | 46 | 0.250 |
Why?
|
| Seizures | 4 | 2011 | 279 | 0.250 |
Why?
|
| Life Change Events | 5 | 2015 | 223 | 0.250 |
Why?
|
| Primary Health Care | 6 | 2007 | 702 | 0.240 |
Why?
|
| Mental Health Services | 3 | 2010 | 199 | 0.240 |
Why?
|
| Implosive Therapy | 3 | 2016 | 171 | 0.230 |
Why?
|
| Health Services Research | 2 | 2004 | 209 | 0.230 |
Why?
|
| Diagnostic and Statistical Manual of Mental Disorders | 5 | 2018 | 257 | 0.230 |
Why?
|
| Severity of Illness Index | 9 | 2018 | 1851 | 0.220 |
Why?
|
| Adult | 31 | 2020 | 21375 | 0.220 |
Why?
|
| Combined Modality Therapy | 8 | 2019 | 951 | 0.210 |
Why?
|
| Lithium | 3 | 2021 | 76 | 0.210 |
Why?
|
| Behavior Therapy | 2 | 2017 | 297 | 0.200 |
Why?
|
| Anxiety Disorders | 4 | 2017 | 426 | 0.200 |
Why?
|
| Cognition Disorders | 3 | 2014 | 342 | 0.190 |
Why?
|
| Mentoring | 1 | 2020 | 53 | 0.180 |
Why?
|
| Neurocognitive Disorders | 1 | 2019 | 23 | 0.180 |
Why?
|
| United States Department of Veterans Affairs | 5 | 2012 | 307 | 0.180 |
Why?
|
| Dental Care | 1 | 2019 | 34 | 0.170 |
Why?
|
| Blood Glucose | 3 | 2017 | 631 | 0.170 |
Why?
|
| Clinical Protocols | 4 | 2014 | 172 | 0.170 |
Why?
|
| Anesthesia, General | 1 | 2019 | 86 | 0.170 |
Why?
|
| Sleep Initiation and Maintenance Disorders | 2 | 2018 | 91 | 0.160 |
Why?
|
| Hospitals, Veterans | 3 | 2014 | 147 | 0.160 |
Why?
|
| Aged, 80 and over | 12 | 2017 | 4843 | 0.160 |
Why?
|
| Health Status | 4 | 2016 | 429 | 0.150 |
Why?
|
| Community Mental Health Centers | 2 | 2007 | 16 | 0.150 |
Why?
|
| Neuropsychological Tests | 6 | 2019 | 517 | 0.140 |
Why?
|
| Research Design | 4 | 2014 | 729 | 0.140 |
Why?
|
| Disaster Victims | 1 | 2015 | 13 | 0.130 |
Why?
|
| Patient Reported Outcome Measures | 1 | 2016 | 114 | 0.130 |
Why?
|
| Health Behavior | 2 | 2020 | 458 | 0.130 |
Why?
|
| Internet | 3 | 2015 | 390 | 0.130 |
Why?
|
| Cyclohexanols | 1 | 2015 | 12 | 0.130 |
Why?
|
| Patient Acceptance of Health Care | 2 | 2012 | 467 | 0.130 |
Why?
|
| Poverty | 3 | 2021 | 218 | 0.120 |
Why?
|
| Infant, Premature | 3 | 2006 | 284 | 0.120 |
Why?
|
| Violence | 2 | 2007 | 275 | 0.120 |
Why?
|
| Ventilator Weaning | 2 | 2004 | 27 | 0.120 |
Why?
|
| Patient Satisfaction | 1 | 2016 | 378 | 0.120 |
Why?
|
| Computer-Assisted Instruction | 1 | 2014 | 74 | 0.120 |
Why?
|
| Remission Induction | 5 | 2016 | 111 | 0.110 |
Why?
|
| Drug Resistance | 3 | 2009 | 223 | 0.110 |
Why?
|
| Randomized Controlled Trials as Topic | 3 | 2021 | 929 | 0.110 |
Why?
|
| Child, Preschool | 1 | 2019 | 3185 | 0.110 |
Why?
|
| Lithium Carbonate | 2 | 2009 | 31 | 0.100 |
Why?
|
| Health Services Needs and Demand | 1 | 2012 | 149 | 0.100 |
Why?
|
| Patient Education as Topic | 1 | 2014 | 424 | 0.100 |
Why?
|
| Interview, Psychological | 2 | 2009 | 113 | 0.100 |
Why?
|
| Bipolar Disorder | 1 | 2014 | 307 | 0.100 |
Why?
|
| Health Services Accessibility | 3 | 2015 | 581 | 0.100 |
Why?
|
| Cognition | 2 | 2016 | 512 | 0.100 |
Why?
|
| Double-Blind Method | 5 | 2016 | 1737 | 0.090 |
Why?
|
| Affective Disorders, Psychotic | 1 | 2010 | 23 | 0.090 |
Why?
|
| Pilot Projects | 3 | 2009 | 1341 | 0.090 |
Why?
|
| Secondary Prevention | 4 | 2017 | 291 | 0.090 |
Why?
|
| Drug Therapy, Combination | 4 | 2017 | 648 | 0.090 |
Why?
|
| Day Care, Medical | 2 | 2007 | 18 | 0.090 |
Why?
|
| Memory Disorders | 1 | 2010 | 111 | 0.090 |
Why?
|
| Schizophrenic Psychology | 1 | 2009 | 53 | 0.080 |
Why?
|
| International Classification of Diseases | 1 | 2009 | 85 | 0.080 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2014 | 766 | 0.080 |
Why?
|
| Memory | 1 | 2010 | 214 | 0.080 |
Why?
|
| Adjustment Disorders | 1 | 2007 | 9 | 0.080 |
Why?
|
| Child | 1 | 2019 | 6400 | 0.080 |
Why?
|
| Telephone | 2 | 2021 | 160 | 0.080 |
Why?
|
| Algorithms | 2 | 2017 | 1194 | 0.080 |
Why?
|
| Military Personnel | 1 | 2010 | 220 | 0.080 |
Why?
|
| Educational Technology | 1 | 2007 | 22 | 0.080 |
Why?
|
| Diagnostic Techniques and Procedures | 1 | 2007 | 12 | 0.080 |
Why?
|
| Respiration, Artificial | 2 | 2006 | 190 | 0.080 |
Why?
|
| Needs Assessment | 2 | 2006 | 185 | 0.080 |
Why?
|
| Patient-Centered Care | 1 | 2008 | 106 | 0.080 |
Why?
|
| Cross-Sectional Studies | 7 | 2007 | 2264 | 0.080 |
Why?
|
| Empathy | 1 | 2007 | 45 | 0.080 |
Why?
|
| Drug Synergism | 1 | 2007 | 260 | 0.070 |
Why?
|
| United States | 9 | 2014 | 7335 | 0.070 |
Why?
|
| Time Factors | 6 | 2014 | 4655 | 0.070 |
Why?
|
| Alcoholism | 1 | 2015 | 1109 | 0.070 |
Why?
|
| Expert Systems | 1 | 2006 | 9 | 0.070 |
Why?
|
| Sertraline | 1 | 2006 | 62 | 0.070 |
Why?
|
| Women's Health Services | 1 | 2006 | 10 | 0.070 |
Why?
|
| Risk Management | 1 | 2006 | 37 | 0.070 |
Why?
|
| Delivery of Health Care | 1 | 2010 | 445 | 0.070 |
Why?
|
| Young Adult | 5 | 2017 | 5708 | 0.070 |
Why?
|
| Respiratory Distress Syndrome, Newborn | 1 | 2006 | 46 | 0.070 |
Why?
|
| Risperidone | 1 | 2005 | 48 | 0.070 |
Why?
|
| Prospective Studies | 4 | 2021 | 3702 | 0.070 |
Why?
|
| Decision Support Systems, Clinical | 1 | 2006 | 88 | 0.060 |
Why?
|
| Anti-Anxiety Agents | 1 | 2005 | 107 | 0.060 |
Why?
|
| Somatoform Disorders | 1 | 2004 | 35 | 0.060 |
Why?
|
| Clinical Competence | 1 | 2010 | 657 | 0.060 |
Why?
|
| Phobic Disorders | 1 | 2006 | 227 | 0.060 |
Why?
|
| Health Personnel | 1 | 2007 | 286 | 0.060 |
Why?
|
| Rural Population | 1 | 2007 | 397 | 0.060 |
Why?
|
| Fear | 1 | 2005 | 239 | 0.060 |
Why?
|
| Suicide | 1 | 2005 | 115 | 0.060 |
Why?
|
| Adolescent | 7 | 2015 | 8903 | 0.060 |
Why?
|
| Motivation | 2 | 2020 | 561 | 0.060 |
Why?
|
| Intubation, Intratracheal | 1 | 2004 | 99 | 0.060 |
Why?
|
| Surveys and Questionnaires | 5 | 2014 | 2798 | 0.060 |
Why?
|
| Antipsychotic Agents | 1 | 2005 | 247 | 0.060 |
Why?
|
| Decision Making, Computer-Assisted | 1 | 2003 | 18 | 0.060 |
Why?
|
| Sex Offenses | 1 | 2005 | 170 | 0.060 |
Why?
|
| Wounds and Injuries | 1 | 2006 | 334 | 0.060 |
Why?
|
| Anxiety | 1 | 2004 | 422 | 0.050 |
Why?
|
| Recurrence | 3 | 2009 | 948 | 0.050 |
Why?
|
| Wisconsin | 1 | 2020 | 30 | 0.050 |
Why?
|
| Socioeconomic Factors | 2 | 2015 | 955 | 0.050 |
Why?
|
| Models, Statistical | 1 | 2004 | 446 | 0.050 |
Why?
|
| Follow-Up Studies | 4 | 2009 | 3256 | 0.050 |
Why?
|
| Stroke | 1 | 2012 | 2161 | 0.040 |
Why?
|
| Minority Groups | 1 | 2020 | 196 | 0.040 |
Why?
|
| Retreatment | 2 | 2008 | 59 | 0.040 |
Why?
|
| Reproducibility of Results | 1 | 2004 | 2077 | 0.040 |
Why?
|
| Blood Pressure | 2 | 2014 | 1447 | 0.040 |
Why?
|
| Chronic Disease | 2 | 2015 | 1329 | 0.040 |
Why?
|
| Prevalence | 3 | 2006 | 1609 | 0.040 |
Why?
|
| Antidepressive Agents, Second-Generation | 1 | 2016 | 53 | 0.040 |
Why?
|
| Substance-Related Disorders | 1 | 2006 | 1241 | 0.040 |
Why?
|
| Medical Audit | 2 | 2006 | 44 | 0.040 |
Why?
|
| Electroencephalography | 2 | 2009 | 418 | 0.040 |
Why?
|
| Chi-Square Distribution | 2 | 2008 | 546 | 0.030 |
Why?
|
| Missouri | 1 | 2015 | 44 | 0.030 |
Why?
|
| Alabama | 1 | 2015 | 98 | 0.030 |
Why?
|
| Pamphlets | 1 | 2014 | 27 | 0.030 |
Why?
|
| Tornadoes | 1 | 2015 | 54 | 0.030 |
Why?
|
| Feedback, Physiological | 1 | 2014 | 38 | 0.030 |
Why?
|
| Cost-Benefit Analysis | 2 | 2009 | 503 | 0.030 |
Why?
|
| Interviews as Topic | 2 | 2006 | 392 | 0.030 |
Why?
|
| Intensive Care Units, Neonatal | 2 | 2006 | 113 | 0.030 |
Why?
|
| Infant, Newborn | 3 | 2006 | 2453 | 0.030 |
Why?
|
| South Carolina | 2 | 2014 | 2750 | 0.030 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2009 | 1745 | 0.030 |
Why?
|
| Disasters | 1 | 2015 | 204 | 0.030 |
Why?
|
| Mental Health | 1 | 2015 | 278 | 0.030 |
Why?
|
| Self Care | 1 | 2014 | 252 | 0.030 |
Why?
|
| Predictive Value of Tests | 2 | 2007 | 1465 | 0.030 |
Why?
|
| Risk Factors | 3 | 2009 | 5719 | 0.030 |
Why?
|
| Program Evaluation | 1 | 2014 | 502 | 0.030 |
Why?
|
| Decision Making | 2 | 2006 | 410 | 0.030 |
Why?
|
| Logistic Models | 2 | 2005 | 1419 | 0.020 |
Why?
|
| Mental Status Schedule | 1 | 2010 | 31 | 0.020 |
Why?
|
| Tape Recording | 1 | 2010 | 6 | 0.020 |
Why?
|
| Afghan Campaign 2001- | 1 | 2010 | 78 | 0.020 |
Why?
|
| Iraq War, 2003-2011 | 1 | 2010 | 85 | 0.020 |
Why?
|
| Office Visits | 1 | 2010 | 83 | 0.020 |
Why?
|
| Antidepressive Agents, Tricyclic | 1 | 2009 | 45 | 0.020 |
Why?
|
| Calibration | 1 | 2009 | 73 | 0.020 |
Why?
|
| Prognosis | 2 | 2006 | 2093 | 0.020 |
Why?
|
| Electrodes | 1 | 2010 | 147 | 0.020 |
Why?
|
| Southeastern United States | 1 | 2010 | 281 | 0.020 |
Why?
|
| Biomarkers | 1 | 2014 | 1593 | 0.020 |
Why?
|
| Personality Inventory | 1 | 2009 | 196 | 0.020 |
Why?
|
| Unnecessary Procedures | 1 | 2008 | 49 | 0.020 |
Why?
|
| Regression Analysis | 1 | 2010 | 737 | 0.020 |
Why?
|
| Long-Term Care | 1 | 2007 | 53 | 0.020 |
Why?
|
| Lorazepam | 1 | 2007 | 54 | 0.020 |
Why?
|
| Thematic Apperception Test | 1 | 2007 | 2 | 0.020 |
Why?
|
| Statistics, Nonparametric | 1 | 2008 | 306 | 0.020 |
Why?
|
| Mentally Ill Persons | 1 | 2007 | 14 | 0.020 |
Why?
|
| Psychomotor Agitation | 1 | 2007 | 63 | 0.020 |
Why?
|
| Sex Characteristics | 1 | 2009 | 295 | 0.020 |
Why?
|
| Treatment Failure | 1 | 2007 | 216 | 0.020 |
Why?
|
| Observer Variation | 1 | 2008 | 330 | 0.020 |
Why?
|
| Hypnotics and Sedatives | 1 | 2007 | 96 | 0.020 |
Why?
|
| Early Diagnosis | 1 | 2007 | 122 | 0.020 |
Why?
|
| Bias | 1 | 2007 | 148 | 0.020 |
Why?
|
| Psychotropic Drugs | 1 | 2007 | 83 | 0.020 |
Why?
|
| Drug Utilization | 1 | 2007 | 119 | 0.020 |
Why?
|
| Medical Records | 1 | 2007 | 121 | 0.020 |
Why?
|
| Attitude of Health Personnel | 1 | 2010 | 442 | 0.020 |
Why?
|
| Programming Languages | 1 | 2006 | 16 | 0.020 |
Why?
|
| Psychopathology | 1 | 2006 | 29 | 0.020 |
Why?
|
| Psychometrics | 1 | 2009 | 514 | 0.020 |
Why?
|
| Patient Dropouts | 1 | 2006 | 98 | 0.020 |
Why?
|
| Drug Prescriptions | 1 | 2007 | 135 | 0.020 |
Why?
|
| Serotonin Antagonists | 1 | 2005 | 31 | 0.020 |
Why?
|
| Morbidity | 1 | 2006 | 130 | 0.020 |
Why?
|
| Functional Laterality | 1 | 2006 | 240 | 0.020 |
Why?
|
| Patient Advocacy | 1 | 2005 | 40 | 0.020 |
Why?
|
| Placebos | 1 | 2005 | 195 | 0.020 |
Why?
|
| Birth Weight | 1 | 2006 | 186 | 0.020 |
Why?
|
| Professional-Patient Relations | 1 | 2005 | 71 | 0.020 |
Why?
|
| Safety | 1 | 2005 | 145 | 0.020 |
Why?
|
| Longitudinal Studies | 1 | 2008 | 1054 | 0.020 |
Why?
|
| Retrospective Studies | 2 | 2010 | 7264 | 0.020 |
Why?
|
| Gestational Age | 1 | 2006 | 389 | 0.020 |
Why?
|
| Proportional Hazards Models | 1 | 2006 | 791 | 0.020 |
Why?
|
| Ambulatory Care | 1 | 2006 | 339 | 0.020 |
Why?
|
| Drug Administration Schedule | 1 | 2005 | 567 | 0.020 |
Why?
|
| Interpersonal Relations | 1 | 2006 | 209 | 0.020 |
Why?
|
| Age Factors | 1 | 2009 | 1860 | 0.020 |
Why?
|
| Social Class | 1 | 2004 | 127 | 0.010 |
Why?
|
| Demography | 1 | 2004 | 279 | 0.010 |
Why?
|
| Disability Evaluation | 1 | 2005 | 298 | 0.010 |
Why?
|
| Aging | 1 | 2009 | 911 | 0.010 |
Why?
|
| Consumer Behavior | 1 | 2003 | 68 | 0.010 |
Why?
|
| ROC Curve | 1 | 2004 | 392 | 0.010 |
Why?
|
| Comorbidity | 1 | 2005 | 1425 | 0.010 |
Why?
|
| Incidence | 1 | 2005 | 1582 | 0.010 |
Why?
|